APC/C – the master controller of origin licensing? by Sivaprasad, Umasundari et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Cell Division
Open Access Commentary
APC/C – the master controller of origin licensing?
Umasundari Sivaprasad, Yuichi J Machida and Anindya Dutta*
Address: Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA
Email: Umasundari Sivaprasad - us6n@virginia.edu; Yuichi J Machida - my8z@virginia.edu; Anindya Dutta* - ad8q@virginia.edu
* Corresponding author    
Abstract
DNA replication must be tightly controlled to prevent initiation of a second round of replication
until mitosis is complete. So far, components of the pre-replicative complex (Cdt1, Cdc6 and
geminin) were considered key players in this regulation. In a new study, Machida and Dutta have
shown that depletion of Emi1 caused cells to replicate their DNA more than once per cell cycle
[1]. This effect was dependent on the ability of Emi1 to inhibit the APC/C. In addition to its role in
regulating entry into mitosis, oscillation of APC/C activity regulates pre-RC formation: high APC/
C activity in late M/G1 allows pre-RC formation and low APC/C activity in S/G2 prevents pre-RC
formation for a second time thereby preventing rereplication. Each redundant pathway to prevent
rereplication is dependent on regulating one of the pre-RC components, and all of the pathways
are co-regulated by Emi1 through the APC/C. In this commentary we discuss how this new role of
Emi1 adds to our understanding of the regulation of replication initiation. We also review the
literature to analyze whether APC/C has a role in regulating endoreduplication (a normal state of
polyploidy in some differentiated cells). Similarly a role of premature APC/C activation in genomic
instability of tumors is discussed.
Background
DNA replication must be restricted to once per cell cycle
and must be followed by mitosis to yield two cells each
with the same amount of DNA. Hence replication is a
tightly regulated process with many redundant pathways
in place to prevent uncontrolled DNA synthesis (rerepli-
cation) and to ensure that each daughter cell receives a
complete complement of chromosomes. To understand
how replication is regulated we must first understand the
factors that are involved in the process and how replica-
tion is controlled during the normal cell cycle.
The cell cycle describes the four stages of cell division. Spe-
cific enzymes called cyclin dependent kinases (cdks)
along with their associated proteins (cyclins) regulate pro-
gression through the cell cycle. Cdk activity is tightly con-
trolled by rapid synthesis and degradation of the
associated cyclin. The first phase is G1 where the cells pre-
pare to synthesize new DNA. Cyclin D/cdk4 activity
increases early in G1 and this results in increased cyclin E/
cdk2 activity late in G1 that promotes entry into the S
phase. DNA synthesis is completed in the S phase and
proper completion of this step is dependent on cyclin A/
cdk2. In G2, cells prepare for division followed by M
phase where the cells undergo mitosis. Cyclin A/cdk1 and
cyclin B/cdk1 activity is required for G2 and M phase pro-
gression. Mitosis results in two daughter cells with a com-
plete copy of the genetic material from the original cell.
The initiation of replication and its regulation is an area of
active study and there are numerous excellent reviews on
this subject [2-4]. Our current understanding of pre-RC
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formation is briefly summarized below. A six-subunit
complex called ORC (origin recognition complex) binds
to discrete regions of the chromosome called origins of
replication. The binding of two proteins Cdt1 and Cdc6
follows, and they in turn recruit the MCM2-7 complex to
the origin. The MCM2-7 complex is the putative replica-
tive helicase that unwinds the DNA and allows down-
stream factors access to the DNA to initiate replication.
The ORC, Cdt1, Cdc6, MCM2-7 complex is called the pre-
RC (pre-replicative complex). Formation of the pre-RC
occurs in the late M and G1 phases of the cell cycle. In late
G1 and S phase, as cyclin E and cyclin A levels increase,
the associated cdks phosphorylate and recruit down-
stream factors to the origins followed by association of
DNA polymerases to initiate new DNA synthesis.
Once the MCM complex is recruited to the origins, a sec-
ond round of replication initiation is prevented by multi-
ple mechanisms. Levels of geminin, a Cdt1 inhibitor,
increase as cells enter S phase. Geminin associates with
Cdt1 and prevents MCM loading on the chromatin. Cdc6
is phosphorylated by cdks and is translocated out of the
nucleus. A portion of Cdt1 is also phosphorylated by cdk2
and targeted for degradation. The end result is prevention
of MCM2-7 complex loading on the chromatin until the
cells have completed mitosis. At the end of mitosis gemi-
nin levels decrease, cdk activity decreases and, as the cells
enter G1, pre-RC formation begins again.
Degradation of Cdt1, Cdc6, geminin and the cyclins is
mediated by two well-coordinated ubiquitin ligases. They
are the SCF (Skp1/Cul1/F-box) and the APC/C (anaphase
promoting complex/cyclosome) complexes (reviewed in
[5]). Among other proteins, the SCF complex regulates the
level of the G1 cyclins, targeting them for degradation
once cells enter S phase. One of several F-box proteins
(the substrate recognition component of the SCF), Fbw7,
binds to cyclin E and catalyzes its ubiquitination, target-
ing the cyclin for proteasomal degradation. The APC/C
complex has two substrate recognition components –
Cdc20 and Cdh1. Each APC/C complex contains either
Cdc20 or Cdh1. This complex is active in the M (APC/
CCdc20) and late M/G1 (APC/CCdh1) phases of the cell
cycle. The repertoire of proteins that the APC/C complex
targets for degradation includes the S and M phase cyclins
(A and B), Cdc6, and geminin.
Emi1 is a negative regulator of APC/C activity (early
mitotic inhibitor 1). Normally Emi1 levels are controlled
by two different mechanisms. Polo-like kinase 1 (Plk1)
phosphorylates Emi1 and targets it for degradation by the
SCFβTRCP complex early in mitosis [6-9]. Emi1 also associ-
ates with a protein called Evi5 [10]. Evi5 binds to Emi1
close to the Plk1 phosphorylation site and protects Emi1
from being phosphorylated and subsequently degraded.
In S phase, as Plk1 levels increase, it targets Evi5 for degra-
dation. This exposes the Plk1 phosphorylation site on
Emi1. Phosphorylation of Emi1 triggers its degradation
early in mitosis, finally activating the APC/C.
Rereplication occurs when pathways controlling pre-RC
formation are disrupted. In mammalian cells, depletion
of geminin or overexpression of Cdt1 is sufficient to cause
rereplication [11-14]. In yeast, premature or constitutive
cdk inactivation is sufficient to cause rereplication
(reviewed in [2]). Whether cdk inactivation (in addition
to disruption of the geminin-Cdt1 balance) is required for
rereplication in mammalian cells has never been clearly
established. However inhibition of cdk activity alone did
cause rereplication in some cell lines [15,16]. A recent
study by Machida and Dutta [1] has identified Emi1 as an
upstream regulator of both the geminin-Cdt1 and cyclin
A-cdk pathways. Emi1 depletion triggers rereplication in
mammalian cells and this is mediated by degradation of
geminin and inhibition of cyclin A associated kinase activ-
ity. Depletion of geminin releases its inhibitory effects on
pre-RC formation allowing Cdt1 to remain active on the
chromatin. Depletion of cyclin A prevents the cyclin A/
cdk complex from phosphorylating Cdt1, Cdc6 and
MCMs, leaving them all active and capable of reforming
the pre-RC even after the first round of replication has
begun. This then allows the origins to fire for a second and
possibly additional rounds of replication. In HCT116
cells, maintaining the geminin-Cdt1 balance alone is suf-
ficient to prevent rereplication. This is consistent with
studies in Drosophila where depletion of either geminin
or cyclin A can induce rereplication [17,18]. In HeLa cells,
however, cdk activity must additionally be inhibited to
induce rereplication [1]. Overexpressing a non-degrada-
ble form of cyclin A was sufficient to prevent rereplication
after Emi1 depletion. This suggests that either of the two
pathways is sufficient for preventing rereplication. This
study also highlights the importance of high cdk activity.
Like the yeast, high cdk activity in HeLa cells is sufficient
to prevent rereplication. However, higher eukaryotes have
evolved additional levels of control (like geminin) to pre-
vent rereplication. Ultimately, both pathways are regu-
lated by the APC/C and both pathways prevent
rereplication in S and G2 phases of the cell cycle by pre-
venting pre-RC formation. While the role of Emi1 in reg-
ulating entry into S and M phases of the cell cycle is well
established, this study reveals its new role as a key regula-
tor of pre-RC formation.
In HCT116 cells, geminin depletion is sufficient to cause
rereplication [1,11,12]. However in HeLa cells, cyclin A
levels must also decrease [1]. It is important to investigate
why the cdk-dependent pathway is ineffective in prevent-
ing rereplication in some cancer cells like HCT116. One
possibility is that the cyclin A-cdk pathway may already beCell Division 2007, 2:8 http://www.celldiv.com/content/2/1/8
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disrupted in HCT116 cells. For example, the levels of the
proteins targeted by the cyclin A/cdk pathway (either Cdt1
or Cdc6) may be elevated in these cells, rendering them
less sensitive to control by cyclin A/cdk. This possibility is
consistent with the observation that overexpression of
Cdt1 and Cdc6, or a non-degradable form of Cdt1 alone
can trigger rereplication in cancer cells [13,14,19] though
additional work is necessary to confirm this model.
APC/C oscillation regulates pre-RC formation
Tight control of APC/C activity is important for proper
pre-RC formation (Figure 1). Emi1 levels increase at the
G1/S transition. This inactivates the APC/C allowing the
accumulation of cyclin A and geminin [20,21]. Cyclin A
associates with the appropriate cdk and phosphorylates
Cdc6, Cdt1 and other proteins. This degrades Cdt1 and
translocates Cdc6 out of the nucleus preventing pre-RC
assembly and thereby a second round or replication.
Geminin associates with the remaining Cdt1 preventing it
from recruiting additional MCM complexes to the origins.
Therefore low APC/C activity in S and G2 phases of the
cell cycle is important to prevent rereplication.
In contrast high APC/C activity is important in G1 to pro-
mote pre-RC formation. The APC/C degrades the mitotic
cyclins and geminin. Degrading the cyclins keeps cdk
activity low in G1. This in turn releases the inhibition of
Cdc6 and allows Cdt1 accumulation, promoting pre-RC
formation. Indeed, Mcm4 loading on the chromatin was
inhibited in cells overexpressing cyclin E, and could be
restored by inhibiting cdk activity [22]. Geminin degrada-
tion also allows Cdt1 to associate with the MCM complex,
APC/C oscillation regulates pre-RC formation Figure 1
APC/C oscillation regulates pre-RC formation. In G1, APC/C activity is high and prevents accumulation of cyclin A and 
geminin, thereby allowing pre-RC formation. At the G1/S transition, Emi1 levels increase, inhibiting the APC/C. This allows the 
accumulation of cyclin A and geminin. Geminin associates with Cdt1 and prevents recruitment of MCM to the origins. Cyclin 
A/cdk phosphorylates Cdc6 (which translocates it out of the nucleus) and Cdt1 (which targets it for degradation by the protea-
some). As cells enter G2, Emi1 is degraded, activating the APC/C. The APC/C then degrades cyclin A and geminin as cells enter 
the next cell cycle.
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allowing cells to reestablish the pre-RC for the next round
of replication. A previous study has shown that overex-
pression of a non-degradable form of geminin prevented
Mcm2 loading on the chromatin and consequently origin
licensing [23]. Therefore APC/C oscillation governs pre-
RC formation by regulating Cdt1-geminin balance and
cdk activity. Emi1, by virtue of its role as the APC/C inhib-
itor, plays a crucial role in preventing rereplication by sta-
bilizing geminin and cyclin A.
APC/C and endoreduplication
While rereplication is strictly prevented in the normal cell
cycle, this strict control over DNA replication is selectively
inactivated during a normal developmental process called
endoreduplication. In humans, this is seen in cells of the
liver and pancreas, trophoblast cells of the placenta and
megakaryocytes [24,25]. During their development/matu-
ration, these cells undergo repeated rounds of DNA syn-
thesis without an intervening mitosis event.
Endoreduplication is also observed in numerous plant
cells [26], along with the follicle cells [27] and salivary
glands of Drosophila [28]. If the APC/C regulates pre-RC
formation, the APC/C may also regulate endoreduplica-
tion. Indeed, there are several lines of evidence from
plants, Drosophila, and mammalian cells to support this
hypothesis.
In plants, cyclin A levels decreased once cells began
endoreduplication and limiting cyclin A degradation pre-
vented endoreduplication [29]. Levels of polyploidy 1, a
repressor of cyclin A, are increased in some endoredupli-
cating Arabidopsis cells and overexpressing this protein is
sufficient to induce endoreduplication [30]. Finally, sev-
eral studies have shown that Ccs52A, the ortholog of
Cdh1 (the subunit of APC/C) is essential for endoredupli-
cation (reviewed in [26]). In one study, the authors dem-
onstrated that cells containing antisense oligos to Ccs52A
did not differentiate into polyploid nitrogen-fixing nod-
ules [31]. While activating the APC/C could be important
for endoreduplication, the role of Emi1 in endoreduplica-
tion of plant cells cannot be determined because there are
no known orthologs of Emi1 in plants.
In Drosophila, fizzy related (fzr), the ortholog of Cdh1 is
required for endoreduplication [28]. In this study, fzr defi-
cient embryos show different phenotypes based on the
cell type. In epidermal cells, fzr deletion triggers rereplica-
tion but in cells of the salivary gland, fzr deletion prevents
endoreduplication. This suggests a cell type specific role
for fzr. Deletion of Rca1, the homolog of Emi1 in Dro-
sophila also yielded cells with giant nuclei and increased
DNA content [32]. While the authors propose that Rca1
may be important for endoreduplication, this has not yet
been established experimentally.
In mammalian cells a direct role of the APC/C in mamma-
lian endoreduplication has yet to be confirmed. One clue
comes from the study of Emi1 knockout mice [33]. The
absence of Emi1 was embryonic lethal. During develop-
ment of Emi1-/- embryos, the trophoblast cells continued
to endoreduplicate like the normal embryo while the
inner cell mass could not proliferate and eventually
underwent apoptosis. This suggests that Emi1 has a role
during the normal cell cycle. However the persistence of
the trophoblast cells in the Emi1-/- embryos suggests that
Emi1 levels may naturally be low in endoreduplicating
cells. More indirect evidence for the role of the APC/C in
endoreduplication comes from studies on APC/C sub-
strates. Decrease in cyclin B (instead of cyclin A) is
required to initiate endoreduplication in megakaryocytes
[34]. Cyclin B is also an APC/C substrate and this is con-
sistent with a role for APC/C activation in endoreduplica-
tion. Recently, researchers attempted to generate a
geminin knockout mouse [35]. This study showed that
homozygous geminin deletions were embryonic lethal.
The egg, after reaching the eight-cell stage, underwent pre-
mature endoreduplication and developed trophoblast
properties without forming any inner cell mass cells
required for formation of the embryo. The common
theme in these studies is the importance of regulating
both the Cdt1-geminin pathway and the cyclin/cdk path-
way, both of which are, in turn, regulated by the APC/C.
In normal cells rereplication activates the DNA damage
checkpoint preventing further DNA replication [36]. Con-
sistent with this, Emi1 depletion activated the DNA dam-
age checkpoint [1]. It is not known whether such
checkpoints are active or inhibited in endoreduplicating
cells. The interplay between endoreduplication and
checkpoint activation during development remains to be
understood. While this research strongly corroborates
what is already known about the role of APC/C in endore-
duplication, there are more questions than answers at this
time regarding this potential role for Emi1 in endoredu-
plication and more research is needed to find the answers.
Implications of rereplication in genomic instability
The significance of two redundant pathways to prevent
rereplication remains to be better understood. Cells might
have developed two overlapping pathways so that even if
one fails the other pathway can regulate pre-RC function.
For example, even if gemininis depleted and cannot
inhibit Cdt1, cyclin A associated cdk2 can phosphorylate
Cdt1 and target it for degradation, thereby preventing
rereplication. Emi1, however, co-regulates both pathways
and loss of Emi1 causes complete loss of replication con-
trol. This could result in genomic instability, a hallmark of
cancers. Genomic instabilities, such as large-scale inser-
tions, deletions, translocations, polyploidy and aneu-
ploidy, are frequently observed when proteins involved inCell Division 2007, 2:8 http://www.celldiv.com/content/2/1/8
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DNA damage checkpoints, DNA replication, and the cell
cycle are affected [37]. Loss of Emi1 could therefore be
another trigger for genomic instability.
While loss of both pathways (e.g. by Emi1 depletion)
cause large-scale rereplication, loss of either geminin or
cyclin A may increase the frequency of micro-rereplication
– rereplication of short segments of DNA that cannot be
easily detected by most assays currently in use. Such spon-
taneous re-firing of origins could result in genomic insta-
bility and promote tumorigenesis. This is consistent with
the observation that Cdt1 and Cdc6 levels are upregulated
in small cell lung carcinomas [38] and that Cdt1 overex-
pression could cause chromosome damage in fibroblasts
[39].
Loss of APC/C regulation has been implicated in cancers.
The Evi5 chromosomal locus is frequently targeted for
recombination in several cancers and a truncated Evi5 is
expressed in a patient with neuroblastoma (reviewed in
[40]). Loss of Evi5 will destabilize Emi1 by triggering its
phosphorylation by Plk1. Numerous studies have also
linked Plk1 overexpression to cancers [41]. Plk1 overex-
pression can trigger Evi5 and Emi1 degradation and acti-
vate the APC/C [9,10]. All these pathways, by indirectly
decreasing Emi1 levels and activating the APC/C, could
ultimately result in genomic instability. Although no stud-
ies so far have directly linked decreased levels of Emi1 the
genomic instability of cancers, this possibility and should
be addressed experimentally.
In summary, the recent study by Machida and Dutta high-
lights the significance of strict control of APC/C activity
throughout the cell cycle. The APC/C controls two redun-
dant pathways to prevent rereplication. Improper activa-
tion of the APC/C by depleting the APC/C inhibitor Emi1
disrupts S phase inhibition of pre-RC activity and allows
rereplication. While there is evidence to suggest that APC/
C activity is critical for normal processes like endoredupli-
cation, and loss of APC/C regulation may be important
for tumorigenesis, the direct involvement of the APC/C in
both these processes remains to be established.
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